DAX Slightly Up; Teladoc Reports Mixed Q2 Results Amid Market Trends
The DAX index closed at 18,479.00 with a 0.23% increase, while gold prices dipped slightly. In significant news, Teladoc Health reported a revenue of $642.4 million for Q2 2024, a 2% decrease year-over-year, alongside a net loss of $837.7 million. Newly appointed CEO Chuck Divita emphasized the need for improved execution and addressing challenges in the BetterHelp segment.
After-Hours Trading Highlights: Meta, Qualcomm, and Arm Stock Movements
After-hours trading reveals significant shifts in the stock market, with companies like Meta Platforms, Qualcomm, and Arm Holdings making headlines due to notable stock movements. Investors are keen to analyze these fluctuations, driven by positive earnings reports and technological advancements. Understanding these trends is crucial for informed investment decisions in the evolving financial landscape.
Teladoc (NYSE:TDOC) Misses Q4 Sales Targets, Stock Drops 13.2%
Teladoc Health (NYSE:TDOC) disappoints in Q4 FY2023 with 3.6% revenue growth, falling short of analyst estimates. The stock drops 13.2% as next quarter’s revenue guidance also misses expectations. With a market capitalization of $3.48 billion, the telemedicine platform faces questions about its future sales growth.